Cargando…

Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding

Innate immune cells constitute a substantial proportion of the cells within the tumor microenvironment. Besides the contribution of the microenvironment to tumor proliferation and survival, there is direct evidence that interactions between tumor cells and their microenvironment alter sensitivity to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirz, Taghreed, Matera, Eva-Laure, Chettab, Kamel, Jordheim, Lars Petter, Mathé, Doriane, Evesque, Anne, Esmenjaud, Justine, Salles, Gilles, Dumontet, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641171/ https://www.ncbi.nlm.nih.gov/pubmed/29069828 http://dx.doi.org/10.18632/oncotarget.20350

Ejemplares similares

Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity
por: Duong, Minh Ngoc, et al.
Publicado: (2015)

Characterization of T‐DM1‐resistant breast cancer cells
por: Sauveur, Juliette, et al.
Publicado: (2020)

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent
por: Grasselly, Chloé, et al.
Publicado: (2018)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
por: Chettab, Kamel, et al.
Publicado: (2023)

Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents
por: Chettab, Kamel, et al.
Publicado: (2015)

Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway
por: Sauveur, Juliette, et al.
Publicado: (2018)

Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines
por: Cadassou, Octavia, et al.
Publicado: (2021)

Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy
por: Denis, Morgane, et al.
Publicado: (2023)

Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib
por: Geneste, A., et al.
Publicado: (2020)

ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo
por: Chong, Deborah L. W., et al.
Publicado: (2021)

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene
por: Galmarini, Carlos María, et al.
Publicado: (2004)

Transmigrated neutrophils in the intestinal lumen engage ICAM 1 to regulate the epithelial barrier and neutrophil recruitment
por: Sumagin, Ronen, et al.
Publicado: (2013)

Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf
por: Cividini, Federico, et al.
Publicado: (2015)

PARP Inhibitors and Proteins Interacting with SLX4
por: Jordheim, Lars Petter
Publicado: (2023)

ICAM-2 facilitates luminal interactions between neutrophils and endothelial cells in vivo
por: Halai, Krishma, et al.
Publicado: (2014)

ADAM10-Mediated Cleavage of ICAM-1 Is Involved in Neutrophil Transendothelial Migration
por: Morsing, Sofia K. H., et al.
Publicado: (2021)

The cytosolic 5′-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells
por: Bricard, Gabriel, et al.
Publicado: (2017)

Neutrophil Interactions with Epithelial Expressed ICAM-1 Enhances Intestinal Mucosal Wound Healing
por: Sumagin, R, et al.
Publicado: (2016)

Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses
Publicado: (1994)

Targeting glutaminase to starve lymphoma cells
por: Dumontet, Charles
Publicado: (2022)

A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen
Publicado: (1993)

A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages
por: Richert, Iseulys, et al.
Publicado: (2023)

Coordinated Redistribution of Leukocyte LFA-1 and Endothelial Cell ICAM-1 Accompany Neutrophil Transmigration
por: Shaw, Sunil K., et al.
Publicado: (2004)

Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells
por: Hage-Sleiman, Rouba, et al.
Publicado: (2010)

The effects of platelet activating factor and retinoic acid on the expression of ELAM-1 and ICAM-1 and the functions of neutrophils
por: Chen, Si-Feng
Publicado: (1995)

Blockade of ICAM-1 Improves the Outcome of Polymicrobial Sepsis via Modulating Neutrophil Migration and Reversing Immunosuppression
por: Zhao, Yan-jun, et al.
Publicado: (2014)

Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer
por: Zhang, Manqi, et al.
Publicado: (2023)

The role of ICAM-2 in neuroblastoma
por: Yoon, Karina J., et al.
Publicado: (2015)

Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3
Publicado: (1994)

Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium
por: Porter, Joanna C., et al.
Publicado: (2009)

ICAM‐1‐targeted nanocarriers attenuate endothelial release of soluble ICAM‐1, an inflammatory regulator
por: Manthe, Rachel L., et al.
Publicado: (2017)

Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)
por: Allende-Vega, Nerea, et al.
Publicado: (2022)

ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells
por: Regev, Ofer, et al.
Publicado: (2022)

LFA-1/ ICAM-1 promotes NK cell cytotoxicity associated with the pathogenesis of ocular toxoplasmosis in murine model
por: Gao, Nannan, et al.
Publicado: (2022)

The role of tazemetostat in relapsed/refractory follicular lymphoma
por: von Keudell, Gottfried, et al.
Publicado: (2021)

Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction
por: Barakat, Khaled H., et al.
Publicado: (2012)

CXC-chemokine regulation and neutrophil trafficking in hepatic ischemia-reperfusion injury in P-selectin/ICAM-1 deficient mice
por: Monson, Keith M, et al.
Publicado: (2007)

Hyperglycemia Decreases Epithelial Cell Proliferation and Attenuates Neutrophil Activity by Reducing ICAM-1 and LFA-1 Expression Levels
por: Qiu, Dongxu, et al.
Publicado: (2020)

ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway
Publicado: (1993)

Prospects in the management of patients with follicular lymphoma beyond first-line therapy
por: Qualls, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_963u03ge17fmaqpgmscbp5bhbl